Cefsumide

Cefsumide

SCHEMBL30688405

CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3cccc(NS(C)(=O)=O)c3)[C@H]2SC1

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 7/20 0.75
▸ MAPT P10636 7/20 0.75
▸ ALDH1A1 P00352 6/20 0.75
▸ KMT2A Q03164 5/20 0.75
▸ CYP3A4 P08684 4/20 0.75
▸ SLC15A2 Q16348 3/20 0.75
▸ HPGD P15428 3/20 0.75
▸ TDP1 Q9NUW8 3/20 0.75
▸ BLM P54132 2/20 0.75
▸ CYP2C19 P33261 2/20 0.75
▸ MAPK1 P28482 2/20 0.75
▸ ADRA1A P35348 1/20 0.75
▸ HTR2B P41595 1/20 0.75
▸ MEN1 O00255 4/20 0.67
▸ LMNA P02545 2/20 0.67
▸ ESR1 P03372 1/20 0.67
▸ SLC22A6 Q4U2R8 1/20 0.67
▸ SLC22A8 Q8TCC7 1/20 0.67
▸ KDM4E B2RXH2 6/20 0.59
▸ CYP2C9 P11712 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cefsumide SCHEMBL612272 1.00 HSD17B10 (0.75) HSD17B10MAPTALDH1A1KMT2ACYP3A4
Cefsumide SCHEMBL11217305 1.00 HSD17B10 (0.75) HSD17B10MAPTALDH1A1KMT2ACYP3A4
SCHEMBL11652216 0.91 ALDH1A1 (0.74) HSD17B10MAPTALDH1A1KMT2ACYP3A4
SCHEMBL11652221 0.91 ALDH1A1 (0.74) HSD17B10MAPTALDH1A1KMT2ACYP3A4
SCHEMBL11655020 0.91 ALDH1A1 (0.74) HSD17B10MAPTALDH1A1KMT2ACYP3A4
SCHEMBL612273 0.90 MAPT (0.76) HSD17B10MAPTALDH1A1KMT2ACYP3A4
SCHEMBL11650995 0.89 PTGS1 (0.59) HSD17B10MAPTALDH1A1KMT2ACYP3A4
SCHEMBL11650999 0.89 PTGS1 (0.59) HSD17B10MAPTALDH1A1KMT2ACYP3A4
SCHEMBL11574032 0.89 HSD17B10 (0.76) HSD17B10MAPTALDH1A1KMT2ACYP3A4
SCHEMBL11574041 0.89 HSD17B10 (0.76) HSD17B10MAPTALDH1A1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117377878-A Method for improving specificity and sensitivity of group A streptococcus immunoassay 贝克顿·迪金森公司 2024-01-09 — — CN disclosed
CN-117338776-A Use of beta-lactams or salts thereof for long-acting prevention or treatment of glucose metabolism disorders 醣解生医股份有限公司 2024-01-05 — — CN disclosed
Send feedback